Search Within

Department of Medicine

Formats
  1. Journal Article (19617)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22346)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10651)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1116)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2119)

More Publishers

Results (39667)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of the genomic stability of herpes simplex virus thymidine kinase variants in retrovirally transduced lymphocytes
    Meeting Abstract

    Capacio, V. L.; Fan, Y.; Stefanski, J.; Chang, A. H.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • Cationic PLG microparticles: A potent delivery system for DNA vaccines
    Meeting Abstract

    Briones, M.; Singh, M.; Turk, M.; Guevara Patino, J.; Wolchok, J.; O'Hagan, D.
    Journal of Investigative Medicine (2004)

    Fulltext@MSK | Save
  • High-grade neuroendocrine carcinomas of the gastrointestinal tract: The Memorial Sloan-Kettering Cancer Center experience of 143 cases
    Meeting Abstract

    Brenner, B.; Shia, J.; Klimstra, D. S.; Gonen, M.; Shah, M. A.; Leonard, G. D.; Kelsen, D. P.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)
    Meeting Abstract

    Boulad, F.; Steinherz, P.; Kernan, N. A.; Small, T. N.; Prasad, V.; Prockop, S.; Kolb, A.; O'Reilly, R. J.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Hematopoietic stem cell transplantation for the treatment of Fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors
    Meeting Abstract

    Boulad, F.; Auerbach, A. D.; Kolb, A.; Small, T. N.; Prasad, V.; Prockop, S.; Torok-Castanza, J.; Casson, A.; Collins, N. H.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Fludarabine (Flu) based cytoreductive regimen and T-cell depleted grafts from unrelated or mismatched related donors for the treatment of high risk patients with Fanconi anemia (FA)
    Meeting Abstract

    Boulad, F.; Auerbach, A. D.; Kernan, N. A.; Small, T. N.; Prockop, S. E.; Chaudhury, S.; Castanza, J.; Casson, A.; Copeland, C.; Abendroth, H.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Duration of response to androgen deprivation therapy and survival after subsequent biochemical relapse in men initially treated with radical prostatectomy
    Meeting Abstract

    Bianco, F. J.; Dotan, Z. A.; Kattan, M. W.; Fearn, P. A.; Scher, H. I.; Eastham, J. A.; Scardino, P. T.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Altered bone and mineral metabolism in patients treated with imatinb
    Meeting Abstract

    Berman, E.; Nicolaides, M.; Sauter, N.; Chanel, S.; Wilson, B.; Fleisher, M.
    Blood (2004)

    Fulltext@MSK | Save
  • Defining a new threshold for PSA outcomes in untreated prostate cancer
    Meeting Abstract

    Beekman, K. W.; Wilton, A.; Heller, G.; Bianco, F. J.; Lilja, H.; Slovin, S.; Scardino, P. T.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save